Medication for Opioid Use Disorder (MOUD) is the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of opioid use disorder.
| MOUD Resources | |
|---|---|
| MAT Rules: Medication Assisted Therapy for Opioid Dependence | Any buprenorphine or methadone prescriber is responsible for complying with these rules. |
| Provider Clinical Support System | Consent documents as referenced in the MAT rule. |
| Opioid Treatment Screening Guidelines for Hubs | The primary goal of MOUD is to improve overall patient wellness. It is recommended that a comprehensive screening for drugs misuse be completed upon entering opioid treatment programs. |
| MAT for Opioid Addiction: Fact Sheet | MAT fact sheet including assessing the evidence, dosage and treatment limits, MAT and pregnancy and risks. |
| MAT Guidelines for Women who are Pregnant | Recommendations for providers on the management of opioid dependence during pregnancy. |
| Buprenorphine Billing Codes for Hubs | HCPCS codes issued in 2015 for Buprenorphine/Naloxone and Buprenorphine. Required to bill by Hubs in order to comply with proper billing practices. These codes replace pre-existing code for Unclassified Drugs, J3490. |
| Opiate Care Alliance of Chittenden County - Consent to Disclose Form | Opiate Care Alliance of Chittenden County Attachment B: Consent to Disclosure of Health Information for Treatment and Coordination of Care |
Training
- Medication Assisted Treatment (MAT) 101 - An introduction to Medication Assisted Treatment (September 2021)
For upcoming training opportunities and continuing education resources on alcohol and drug prevention, intervention, treatment and recovery for health professionals. visit our Workforce Development page.